Kiromic BioPharma, Inc. (KRBPQ)
OTCMKTS · Delayed Price · Currency is USD
0.0001
+0.0001 (9,900.00%)
Oct 6, 2026, 3:41 PM EDT
Kiromic BioPharma Market Cap
Kiromic BioPharma has a market cap or net worth of $157 as of October 7, 2026. That makes Kiromic BioPharma the world's 52,791st most valuable company and 8,809th in the United States. Its market cap has decreased by 98.00% in one year.
Market Cap
157.00
Enterprise Value
n/a
Revenue
n/a
Global Rank
Country Rank
#8,809 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since October 16, 2020, Kiromic BioPharma's market cap has decreased from 84.33M to 157.00, a decrease of -100.00%. That is a compound annual growth rate of -89.02%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 5, 2026 | 157.00 | 7,750.00% |
| Dec 30, 2025 | 2.00 | -100.00% |
| Dec 31, 2024 | 1.38M | 26.04% |
| Dec 29, 2023 | 1.09M | -66.79% |
| Dec 30, 2022 | 3.30M | -86.04% |
| Dec 31, 2021 | 23.62M | -61.97% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| HAVN Life Sciences | 29.00 |
| Neurobiological Technologies | 27.00 |
| Verde Science | 24.00 |
| Sienna Biopharmaceuticals | 23.00 |
| IMV Inc. | 15.00 |
| 9 Meters Biopharma | 14.00 |
| PhaseRx | 12.00 |
| ContraFect | 11.00 |